PMID- 19403161 OWN - NLM STAT- MEDLINE DCOM- 20100816 LR - 20161125 IS - 1618-0372 (Electronic) IS - 0065-1281 (Linking) VI - 112 IP - 3 DP - 2010 May TI - Bone formation in a rat calvarial defect model after transplanting autogenous bone marrow with beta-tricalcium phosphate. PG - 270-7 LID - 10.1016/j.acthis.2009.01.003 [doi] AB - In the present study, we evaluated the osteogenic potential of an autogenous bone marrow graft combined with beta-tricalcium phosphate (beta-TCP) in a rat calvarial bone defect model. The bone marrow harvested from the tibia of 7-week-old rats was grafted autogenously in a calvarial defect together with beta-TCP (=BTG group, n=16) or without beta-TCP (=BG group, n=16). Groups of animals were also treated with beta-TCP alone (=TG group, n=16) and control animals (n=8) received no graft implanted into the defect. We then observed the process of bone formation by histology, enzyme histochemistry and immunohistochemistry. Five days after grafting, in the BTG and BG groups, cell proliferation and osteogenic differentiation were observed. From 5 to 10 days after surgery, active Runx2, osteopontin (OPN), and TRAP- positive cells appeared in the BTG and BG groups. New bone formation started in the defect in both the BTG and BG groups. At 30 days after grafting, the BTG group showed new bone development and replacement of beta-TCP to fill the bone defect. New bone formation in the BTG group was significantly greater than in the BG group (P<0.01). The TG group showed no marked bone formation in the defect. The combination graft of bone marrow with beta-TCP showed marked bone formation in rat calvarial defects. Our results indicate that the combination grafts of bone marrow with beta-TCP may be an effective technique for repairing bone defects Beta-TCPgraft (TG) group. CI - 2009 Elsevier GmbH. All rights reserved. FAU - Shirasu, Nobuaki AU - Shirasu N AD - Department of Oral and Maxillofacial Reconstructive Surgery, Okayama University Medical and Dental School, 2-5-1 Shikata, Okayama-city 7008525, Japan. FAU - Ueno, Takaaki AU - Ueno T FAU - Hirata, Yasuhisa AU - Hirata Y FAU - Hirata, Azumi AU - Hirata A FAU - Kagawa, Toshimasa AU - Kagawa T FAU - Kanou, Miwa AU - Kanou M FAU - Sawaki, Masako AU - Sawaki M FAU - Wakimoto, Mari AU - Wakimoto M FAU - Ota, Akiko AU - Ota A FAU - Imura, Hideto AU - Imura H FAU - Matsumura, Tatsushi AU - Matsumura T FAU - Yamada, Tomohiro AU - Yamada T FAU - Yamachika, Eiki AU - Yamachika E FAU - Sano, Kazuo AU - Sano K LA - eng PT - Journal Article DEP - 20090429 PL - Germany TA - Acta Histochem JT - Acta histochemica JID - 0370320 RN - 0 (Biocompatible Materials) RN - 0 (Bone Substitutes) RN - 0 (Calcium Phosphates) RN - 0 (Core Binding Factor Alpha 1 Subunit) RN - 0 (Isoenzymes) RN - 0 (beta-tricalcium phosphate) RN - 106441-73-0 (Osteopontin) RN - EC 3.1.3.2 (Acid Phosphatase) RN - EC 3.1.3.2 (Tartrate-Resistant Acid Phosphatase) SB - IM MH - Acid Phosphatase/metabolism MH - Animals MH - Biocompatible Materials/*pharmacology MH - Bone Marrow Cells/cytology/drug effects/*metabolism MH - *Bone Marrow Transplantation MH - *Bone Regeneration MH - Bone Substitutes/pharmacology MH - Calcium Phosphates/*pharmacology MH - Cell Differentiation MH - Cell Proliferation MH - Core Binding Factor Alpha 1 Subunit/metabolism MH - Disease Models, Animal MH - Isoenzymes/metabolism MH - Male MH - *Osteogenesis/drug effects/physiology MH - Osteopontin/metabolism MH - Rats MH - Skull/injuries/pathology MH - Tartrate-Resistant Acid Phosphatase MH - Tissue Engineering MH - Wound Healing/drug effects/physiology EDAT- 2009/05/01 09:00 MHDA- 2010/08/17 06:00 CRDT- 2009/05/01 09:00 PHST- 2008/08/17 00:00 [received] PHST- 2009/01/13 00:00 [revised] PHST- 2009/01/26 00:00 [accepted] PHST- 2009/05/01 09:00 [entrez] PHST- 2009/05/01 09:00 [pubmed] PHST- 2010/08/17 06:00 [medline] AID - S0065-1281(09)00005-1 [pii] AID - 10.1016/j.acthis.2009.01.003 [doi] PST - ppublish SO - Acta Histochem. 2010 May;112(3):270-7. doi: 10.1016/j.acthis.2009.01.003. Epub 2009 Apr 29.